Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

What Amazon’s foray into the pharmacy business could mean for Big Pharma

By Brian Buntz | January 28, 2021

Amazon Pharmacy

Image courtesy of Amazon

“We bring the pharmacy to you.” 

That’s a recent advertising slogan from online shopping behemoth Amazon (NSDQ:AMZN), which unveiled its plan to deliver prescriptions in November. 

One of the key selling points of its service is prescription savings. The company promises that Amazon Prime members who pay without insurance can save anywhere from 80% of generics and 40% off brand name medications. 

The company could ultimately influence pricing dynamics throughout the industry, but it could be some time before the company makes its presence felt. “Amazon is at the very early stage of offering prescription drugs, and they are a long way off from having pricing power with Big Pharma,” said Avenue7Media CEO and e-commerce expert Jason Boyce. 

By selling common drugs at low prices, the company could put indirect pricing pressure on pharmaceutical manufacturers while also siphoning business from independent and retail pharmacies. 

Amazon could “create efficiencies and squeeze pharmacy retailers,” Boyce said. They could also become or purchase a pharmacy benefits manager. 

Given Amazon’s growing private label brand AmazonBasics, it’s also plausible that the company could purchase a generic drug producer, Boyce added. 

To deal with the situation, pharmaceutical manufacturers “must both focus on the best possible cooperation with all players, including Amazon Pharmacy, and find a way to strengthen their direct connection to the customer and limit their dependence on Amazon Pharmacy,” according to an e-mailed statement from Simon-Kucher & Partners.

But many powerful tech companies have stumbled when attempting to enter the healthcare market, an industry that often has a steep learning curve. “I think Amazon will learn fast that pharma has a lot more roadblocks than other categories they’ve entered,” Boyce said. “However, they will keep learning and growing and they won’t stop.”  

Tell Us What You Think! Cancel reply

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
GSK
Unilever gives up hunt for GSK consumer unit
Prescription drugs
Drug prescription volume growth climbed to 21% in late May
computer laptop
New Bioscience Website Features Scientific Data And Educational Materials

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards